The following table details the insider trading activities
(stock purchases, stock sales, and stock option exercises) of Shannon James Samuel since 2018.
This trader's CIK number is 1485417.
At the time of last reporting, Shannon James Samuel was the Officer of Xilio Therapeutics, Inc.. (stock ticker symbol XLO).
Also see all insider trading activities at Xilio Therapeutics, Inc..
Insider Buying | Insider Sales | Option Exercises | |||||
---|---|---|---|---|---|---|---|
Year | Symbol | Shares | Value | Shares | Value | Shares | Value |
2023 | HZNP | 0 | $0 | 0 | $0 | 15,763 | $144,451 |
2022 | HZNP | 0 | $0 | 0 | $0 | 4,223 | $0 |
2021 | HZNP | 0 | $0 | 7,232 | $660,259 | 7,232 | $88,158 |
2020 | HZNP | 0 | $0 | 0 | $0 | 23,594 | $0 |
2019 | HZNP | 0 | $0 | 25,000 | $660,934 | 48,523 | $304,750 |
2018 | HZNP | 0 | $0 | 0 | $0 | 8,203 | $0 |
Insider Buying | Insider Sales | Option Exercises | |||||
---|---|---|---|---|---|---|---|
Year | Symbol | Shares | Value | Shares | Value | Shares | Value |
2025 | XLO | 70,000 | $48,095 | 0 | $0 | 0 | $0 |
1. Horizon Therapeutics Public Ltd Co (HZNP)
2. Xilio Therapeutics, Inc. (XLO)
Trade Date | Symbol | Trade Type | Shares | Price ($) | Value ($) |
---|---|---|---|---|---|
2023-09-29 | HZNP | Option Ex | 11,850 | 12.19 | 144,451 |
2023-04-28 | HZNP | Option Ex | 3,913 | .00 | 0 |
2022-04-29 | HZNP | Option Ex | 4,223 | .00 | 0 |
2021-03-01 | HZNP | Sale | 7,232 | 91.30 | 660,259 |
2021-03-01 | HZNP | Option Ex | 7,232 | 12.19 | 88,158 |
2020-08-02 | HZNP | Option Ex | 8,204 | .00 | 0 |
2020-05-02 | HZNP | Option Ex | 15,390 | .00 | 0 |
2019-09-12 | HZNP | Option Ex | 15,500 | 12.19 | 188,945 |
2019-09-13 | HZNP | Option Ex | 9,500 | 12.19 | 115,805 |
2019-09-12 | HZNP | Sale | 15,500 | 26.59 | 412,129 |
2019-09-13 | HZNP | Sale | 9,500 | 26.19 | 248,805 |
2019-08-02 | HZNP | Option Ex | 8,203 | .00 | 0 |
2019-05-03 | HZNP | Option Ex | 15,320 | .00 | 0 |
2018-08-02 | HZNP | Option Ex | 8,203 | .00 | 0 |
Trade Date | Symbol | Trade Type | Shares | Price ($) | Value ($) |
---|---|---|---|---|---|
2025-06-16 | XLO | Buy | 45,000 | .69 | 30,870 |
2025-06-17 | XLO | Buy | 25,000 | .69 | 17,225 |
Insider trading activities including stock purchases, stock sales, and option exercises listed in the above table cannot be completely guaranteed as to their accuracy. For more information regarding the trades made by Shannon James Samuel (Officer of Xilio Therapeutics, Inc. at the time of this reporting) see the Securities and Exchange Commission (SEC) website.